Doctoral course: From Research to ATMP Treatment
Karolinska Institutet offers a two-week doctoral course designed to provide a comprehensive overview of the entire process involved in developing and producing cell and gene therapy products. From early-stage research to manufacturing, the program covers key aspects including process development, quality assurance, regulatory frameworks, and logistics.
The course is primarily intended for doctoral students enrolled in the National ATMP Research School. However, a limited number of spots are available for other KI doctoral students with an interest in advanced therapy medicinal products (ATMPs).
By the end of the module, participants will have acquired fundamental knowledge of how to establish production of a cell or gene therapy product in compliance with good manufacturing practice (GMP) standards, an essential step in translating innovative therapies from lab bench to patient care.
Apply for the course: Autumn 2026
- Application period: 2026-04-15 - 2026-05-06
- Course dates: Week 42 and 43, 12-23 October 2026
- Course format: On site at ANA Futura at Karolinska Institutet Campus South.